• Home
  • Contact Us

Soin Neuroscience

Developing treatments for chronic diseases

Developing treatments for chronic diseases
  • Home
  • About Us
  • Research & Development
    • Peripheral Arterial Disease
    • Diabetic Neuropathy
    • Additional Programs
  • Publications
    • Journal Articles
    • PAD, Diabetes & CLI Articles
    • Nitrite Articles
    • News Stories
  • Press Releases
  • Related Links
  • Contact Us
Home / Press Releases

Press Releases

Breaking News From Soin Neuroscience

Press Releases

Dr. Amol Soin Is Interviewed On Local Dayton TV

Watch the interview of Dr. Amol Soin on Fox 45 in Dayton as he explains our new experimental diabetic pain...
Read More

Hillsboro doctor develops new experimental diabetic neuropathy treatment

Highland County Press Dr. Amol Soin, Medical Director of the Ohio Pain Clinic, with an office in Hillsboro, has announced...
Read More

Dayton-area entrepreneur on cusp of ‘billion-dollar’ product (Exclusive)

by Tristan Navera Dayton Business Journal - Febuary 4, 2015 Dr. Amol Soin is setting his sights on a new...
Read More

TheraVasc Releases Phase I Trial Data Demonstrating Safety of Drug in Diabetic Patients

CLEVELAND, Sept. 20, 2011 /PRNewswire/ -- TheraVasc (www.theravasc.com) announced the successful completion of a Phase I clinical trial of a...
Read More

TheraVasc’s clinical trial of PAD drug shows safety in diabetic patients

A phase 1 trial of a peripheral artery disease drug candidate from TheraVasc demonstrated safety in diabetic patients. The positive...
Read More

Startup Stories: A Race for Better Healing Therapies

Tony Giordano / President & CEO of TheraVasc - I am a molecular biologist with a Ph.D. from Ohio State...
Read More

Peripheral artery disease pill from TheraVasc heading to phase 2a trials

TheraVasc plans to begin enrolling patients this month in a phase 2a clinical trial of its pill designed to treat...
Read More

Peripheral artery disease drug developer TheraVasc raises $1.8M

TheraVasc Inc., which is reformulating a drug to treat vascular diseases, has raised $1.8 million in its first round of...
Read More

TheraVasc Awarded “Most Promising Life Science Technology Company” at Rice Alliance Life Science Venture Forum

Houston, TX, August, 19, 2009 - TheraVasc, LLC was named one of the most promising Life Science companies at the...
Read More
Reach Out To Us

Reach Out To Us

Learn more about our current treatments now.

Contact Us

Recent Releases

  • TheraVasc Awarded “Most Promising Life Science Technology Company” at Rice Alliance Life Science Venture Forum
  • Peripheral artery disease drug developer TheraVasc raises $1.8M
  • Peripheral artery disease pill from TheraVasc heading to phase 2a trials
  • Startup Stories: A Race for Better Healing Therapies
  • TheraVasc’s clinical trial of PAD drug shows safety in diabetic patients
  • TheraVasc Releases Phase I Trial Data Demonstrating Safety of Drug in Diabetic Patients

Company

  • About Us
  • Press Releases
  • Related Links
  • Contact Us

Contact Us

Amol Soin, MD, MBA
7076 Corporate Way
Dayton, OH 45458
drsoin@soinneuroscience.com


7076 Corporate Way
Dayton, OH 45458
drsoin@soinneuroscience.com

Research

  • Peripheral Arterial Disease
  • Diabetic Neuropathy
  • Additional Programs

Publications

  • Journal Articles
  • PAD, Diabetes & CLI Articles
  • Nitrite Articles
  • News Stories

Company

  • About Us
  • Press Releases
  • Related Links
  • Contact Us
Copyright © 2023 Soin Neuroscience. All Rights Reserved.

MENU
  • Home
  • About Us
  • Research & Development
    • Peripheral Arterial Disease
    • Diabetic Neuropathy
    • Additional Programs
  • Publications
    • Journal Articles
    • PAD, Diabetes & CLI Articles
    • Nitrite Articles
    • News Stories
  • Press Releases
  • Related Links
  • Contact Us